IP Verse

Generics Uk Trading Mylan competitive analysis

Loading summary...

Latest oppositions filed by Generics Uk Trading Mylan

Explore patent oppositions filed by Generics Uk Trading Mylan against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2653873
Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAJul 20, 2022
EP2785702
Crystalline Dapagliflozin HydrateSANDOZOct 22, 2020
EP2371361
Methods To Mobilize Progenitor/Stem CellsGENZYMEMay 4, 2020
EP2630962
Low Frequency Glatiramer Acetate TherapyYEDA RESEARCHMar 25, 2019
EP3199172
Dosing Regimen For Multiple SclerosisYEDA RESEARCHMar 25, 2019
EP2420223
Aqueous Pharmaceutical Compositions Containing Borate-Polyol ComplexesALCON RESEARCHApr 19, 2018
EP3000810
N3 Alkylated Benzimidazole Derivative As Mek InhibitorARRAY BIOPHARMAApr 19, 2018
EP2308466
Aqueous Pharmaceutical Compositions Containing Borate-Polyol ComplexesALCON RESEARCHFeb 28, 2018
EP3042646
Pharmaceutical Compositions Having Desirable BioavailabilityALCON RESEARCHFeb 9, 2018
EP2599475
Pharmaceutical Composition Having Desirable BioavailabilityALCON RESEARCHJan 26, 2018

Latest publications and patents of Generics Uk Trading Mylan New

Explore the latest publications and patents granted to Generics Uk Trading Mylan, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Generics Uk Trading Mylan

Discover the latest PTAB cases involving Generics Uk Trading Mylan, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Generics Uk Trading Mylan with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GENERICS UK TRADING MYLAN13 - - -
ALCON RESEARCH - 1418
NOVARTIS6422 - 21
YEDA RESEARCH - 21 - 9